- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Improved outcome at end of treatment in the collaborative Wilms tumour Africa project
-
- Trijn Israels
- Academy outreach and Department of solid tumours Princess Máxima Center for Paediatric Oncology Utrecht The Netherlands
-
- Vivian Paintsil
- Department of Child Health Komfo Anokye Teaching Hospital Kumasi Ghana
-
- Dalida Nyirenda
- Department of Paediatrics College of Medicine Blantyre Malawi
-
- Francine Kouya
- Department of Paediatric Oncology Mbingo Baptist Hospital Mbingo Cameroon
-
- Glenn Mbah Afungchwi
- Department of Paediatrics Banso Baptist Hospital Banso Cameroon
-
- Peter Hesseling
- Department of Paediatrics and Child Health Stellenbosch University Cape Town South Africa
-
- Clara Tump
- Department of Artificial Intelligence University of Amsterdam Amsterdam The Netherlands
-
- Gertjan Kaspers
- Academy outreach and Department of solid tumours Princess Máxima Center for Paediatric Oncology Utrecht The Netherlands
-
- Liz Burns
- Head of Operations World Child Cancer London United Kingdom
-
- Ramandeep Singh Arora
- Department of pediatric oncology Max Super‐Specialty Hospital New Delhi India
-
- George Chagaluka
- Department of Paediatrics College of Medicine Blantyre Malawi
-
- Philippa Nana
- Department of Paediatric Oncology Mbingo Baptist Hospital Mbingo Cameroon
-
- Lorna Renner
- Department of Child Health University of Ghana School of Medicine and Dentistry Accra Ghana
-
- Elizabeth Molyneux
- Department of Paediatrics College of Medicine Blantyre Malawi
Search this article
Description
<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>The Collaborative Wilms Tumour (WT) Africa Project has implemented an adapted WT treatment guideline in sub‐Saharan Africa as a multi‐centre prospective clinical trial. A retrospective, baseline evaluation of end‐of‐treatment outcome was performed for a 2‐year period prior to the introduction of this guideline. The collaborative project aims to reduce both treatment abandonment and death during treatment to less than 10% for improving survival.</jats:p></jats:sec><jats:sec><jats:title>Procedure</jats:title><jats:p>All participating centres obtained local Institutional Research Board (IRB) approval and implemented the adapted WT treatment guideline. End‐of‐treatment outcome was documented for 2 years. It was divided into alive without evidence of disease, treatment abandonment, death during treatment and persistent disease. The outcome of children enroled in the first 2 years of the prospective clinical trial has been compared to the outcome before the start of the project.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>One hundred twenty‐two patients were included in the baseline evaluation (2011–2012) and 133 in the first 2 years of the collaborative clinical trial (2014–2015). The percentage of patients alive without evidence of disease at the end of treatment increased from 52% (63/122) to 68% (90/133; <jats:italic>P</jats:italic> = 0.01). Treatment abandonment decreased from 23% (28/122) to 13% (17/133; <jats:italic>P</jats:italic> = 0.03). Death during treatment decreased from 21% (26/122) to 13% (17/133; <jats:italic>P</jats:italic> = 0.07).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>This collaboration, using relatively simple and low‐cost interventions, led to a significant decrease in treatment abandonment and increase in survival without evidence of disease at the end of treatment.</jats:p></jats:sec>
Journal
-
- Pediatric Blood & Cancer
-
Pediatric Blood & Cancer 65 (5), 2018-01-19
Wiley
- Tweet
Details 詳細情報について
-
- CRID
- 1360857596819484928
-
- ISSN
- 15455017
- 15455009
-
- Data Source
-
- Crossref